CanSino Biologics Inc. ( CASBF) - Key Metrics
CASBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $1.29 | $0.05 | ? | ? |
| 2025Q3 | $1.70 | $0.15 | $0.17 | -$0.08 |
| 2025Q2 | $0.79 | -$0.01 | $0.08 | -$0.14 |
| 2025Q1 | $0.59 | -$0.05 | -$0.03 | -$0.32 |
| 2024Q4 | ? | ? | ? | ? |
CASBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 341.03 |
| 2025Q3 | 40.14% | 129.99 |
| 2025Q2 | -638.80% | -2370.79 |
| 2025Q1 | -112.82% | -291.65 |
| 2024Q4 | ? | ? |
CASBF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | -0.13% | 0.08% |
| 2025Q2 | -0.59% | 0.07% |
| 2025Q1 | -1.05% | 0.10% |
| 2024Q4 | -0.16% | ? |
CASBF
Price: $3.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.10 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.0 billion